Vice President, Studylog SystemsBiography
Eric Ibsen co-founded Studylog Systems in 2003, bringing to Studylog extensive international experience in, pharmacology, animal modeling, toxicology and quality assurance in the biopharmaceutical industry. At PDL BioPharma, Ibsen conducted essential in vivo research in toxicology, oncology, inflammation and animal model development. Ibsen contributed to a successful drug discovery effort in oncology as a Scientist at Eos Biotechnology. From 1983 to 2001 he performed pharmacology research in a variety of organizations, including the Stehlin Foundation for Cancer Research, Cetus Corporation, XOMA Corporation, Bayer AG (Germany), Genentech and Theravance.